NM_001130438.3:c.55C>T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_001130438.3(SPTAN1):c.55C>T(p.Arg19Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001130438.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia Pathogenic:4
- -
Criteria applied: PS4,PS2_MOD,PS3_SUP,PM2_SUP,PP1,PP2 -
PS4, PM2, PP2, PP5 - The variant has been reported in ClinVar as Pathogenic by other laboratories (Variation ID 427111). This variant has been previously reported as causative for epileptic encephalopathy, spasticp araplegia and ataxia. (PMID:36331550, 35150594). -
- -
SPTAN1-related disorder Pathogenic:2
- -
The SPTAN1 c.55C>T variant is predicted to result in the amino acid substitution p.Arg19Trp. This variant has been reported to be de novo and to segregate with disease in multiple individuals and families with spastic paraplegia (Van de Vondel et al. 2022. PubMed ID: 35150594; Table S1, Kaplanis et al. 2020. PubMed ID: 33057194; Supplemental Data 3, Zhou et al. 2022. PubMed ID: 35982159; Morsy et al. 2022. PubMed ID: 36331550). Functional studies suggest this variant disrupts protein function (Morsy et al. 2022. PubMed ID: 36331550). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. -
not provided Pathogenic:1Uncertain:1
- -
Identified in multiple individuals with a neuromuscular phenotype previously tested a GeneDx, including multiple de novo cases with confirmed parentage; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36331550, 35150594, 38168508, 35982159, 33057194) -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 19 of the SPTAN1 protein (p.Arg19Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with SPTAN1-related conditions (PMID: 35150594). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 427111). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SPTAN1 protein function. For these reasons, this variant has been classified as Pathogenic. -
Hereditary spastic paraplegia Pathogenic:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with developmental and epileptic encephalopathy 5 (MIM#613477) and hereditary spastic paraplegia MONDO:0019064, SPTAN1-related. Loss of function variants have been reported for both conditions (PMID: 35150594). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Intrafamilial variability has been described (PMID: 32811770, PMID: 31332438). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated tetramerization domain (PMID: 36331550). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as a VUS, but more recently as pathogenic and observed in many individuals with pure or complex hereditary spastic paraplegia. In some individuals, the variant was de novo (ClinVar, PMID: 36331550, PMID: 35150594). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at